Latest filing published 31 Jan 2017 for Novelion Therapeutics Inc..
No signal scores available.
Sandford Smith appears in our data through filings on Novelion Therapeutics Inc. shares, published by SEDI. The record holds 2 filings, for trades running from 16 December 2016 to 27 January 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 31 January 2017, reports a transaction in Novelion Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations